Mayo Endoscopic Subscore at Week 24 Is a Predictor of Future Loss of Response to Vedolizumab in Patients with Ulcerative Colitis in Clinical Remission
Authors
- Hiromu Morikubo (ORCID: https://orcid.org/0000-0002-1232-5879)
- Daisuke Saito (ORCID: https://orcid.org/0000-0003-3200-579X)
- Jun Miyoshi (ORCID: https://orcid.org/0000-0002-6883-1930)
- Tatsuya Mitsui
- Tadakazu Hisamatsu (ORCID: https://orcid.org/0000-0002-1178-3536)
- Teppei Omori (ORCID: https://orcid.org/0000-0002-9959-5168)
- Noriaki Oguri (ORCID: https://orcid.org/0000-0001-8243-6059)
- Minoru Matsuura (ORCID: https://orcid.org/0000-0001-9590-2370)
- Mari Hayashida (ORCID: https://orcid.org/0000-0002-6267-978X)
- Haruka Wada (ORCID: https://orcid.org/0000-0001-7436-8367)
- Noritaka Hibi
- Haruka Komatsu
- Takeshi Fujima
- Ryota Ogihara
Institutions
- Kyorin University (JP)
- Tharawal Aboriginal (AU)
Publication Details
- Journal
- Inflammatory Intestinal Diseases
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1159/000549404
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare